Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Global Tuberculosis Report. (World Health Organization, 2017).
2. Zumla, A. I. et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis 14, 327–340 (2014).
3. Mikušová, K., Makarov, V. & Neres, J. DprE1 – from the Discovery to the Promising Tuberculosis Drug Target. Curr. Pharm. Design 20, 4249–4273 (2014).
4. Makarov, V. et al. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324, 801–804 (2009).
5. Mikušová, K. et al. Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose. J Bacteriol 187, 8020–8025 (2005).
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献